Literature DB >> 3688903

Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome.

M Duvic1, T M Johnson, R P Rapini, T Freese, G Brewton, A Rios.   

Abstract

Human immunodeficiency virus (HIV) causes a spectrum of immunodysfunction, the most severe of which is the acquired immunodeficiency syndrome (AIDS). We have followed the course of psoriasis in 13 patients over 2 1/2 years in a population of more than 1000 HIV-positive individuals. Four patients had a history of mild psoriasis that became severe and uncontrollable as symptoms of immunodeficiency developed. Psoriasis and HIV positivity, AIDS-related complex, or AIDS simultaneously developed in nine patients. In addition to psoriasis, Reiter's syndrome (arthritis, urethritis, and conjunctivitis) developed in one patient in the first group and three patients in the second group. Opportunistic infections, especially candidiasis and Staphylococcus, drugs, and an altered immune system may contribute to the development or flare of psoriasis in these patients. The appearance of severe psoriasis (especially in a patient with other risk factors for HIV) should prompt evaluation for HIV, and may be a poor prognostic indicator in HIV-positive patients, since nine of our 13 patients have died. Immunosuppressive therapy with methotrexate is contraindicated in this group of patients. Newer forms of drug therapy including etretinate show promising results for the management of AIDS-associated psoriasis.

Entities:  

Mesh:

Year:  1987        PMID: 3688903

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  19 in total

Review 1.  Immunological mechanisms involved in psoriasis.

Authors:  C E Griffiths; J J Voorhees
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Is There a Potential Role for Anti-tumor Necrosis Factor Therapy in Patients with Human Immunodeficiency Virus?

Authors:  Jason J Emer
Journal:  J Clin Aesthet Dermatol       Date:  2009-04

Review 3.  Autoimmunity and autoimmune co-morbidities in psoriasis.

Authors:  Kazuhisa Furue; Takamichi Ito; Gaku Tsuji; Takafumi Kadono; Takeshi Nakahara; Masutaka Furue
Journal:  Immunology       Date:  2018-02-06       Impact factor: 7.397

Review 4.  HIV-Related Skin Disease in the Era of Antiretroviral Therapy: Recognition and Management.

Authors:  Khatiya Chelidze; Cristina Thomas; Aileen Yenting Chang; Esther Ellen Freeman
Journal:  Am J Clin Dermatol       Date:  2019-06       Impact factor: 7.403

5.  Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314.

Authors:  Priscilla Y Hsue; Heather J Ribaudo; Steven G Deeks; Tanvir Bell; Paul M Ridker; Carl Fichtenbaum; Eric S Daar; Diane Havlir; Eunice Yeh; Ahmed Tawakol; Michael Lederman; Judith S Currier; James H Stein
Journal:  Clin Infect Dis       Date:  2019-05-17       Impact factor: 9.079

6.  Ostraceous and inverse psoriasis with psoriatic arthritis as the presenting features of advanced HIV infection.

Authors:  Rochelle Lorenzo Castillo; Geraldine Zamora Racaza; Francisca Dela Cruz Roa
Journal:  Singapore Med J       Date:  2014-04       Impact factor: 1.858

7.  Hydroxyurea for the Treatment of Psoriasis including in HIV-infected Individuals: A Review.

Authors:  Eric S Lee; Misha M Heller; Faranak Kamangar; Kelly Park; Wilson Liao; John Koo
Journal:  Psoriasis Forum       Date:  2011

8.  Human immunodeficiency virus (HIV) transcripts identified in HIV-related psoriasis and Kaposi's sarcoma lesions.

Authors:  S E Mahoney; M Duvic; B J Nickoloff; M Minshall; L C Smith; C E Griffiths; S W Paddock; D E Lewis
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 9.  Recognition and treatment of psoriasis. Special considerations in elderly patients.

Authors:  C Bonifati; M Carducci; A Mussi; L D'Auria; F Ameglio
Journal:  Drugs Aging       Date:  1998-03       Impact factor: 3.923

Review 10.  Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  H D Langtry; D M Campoli-Richards
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.